(RAPT) stock quote, history, news, and other essential information to make investment and trading decisions. RAPT Therapeutics NASDAQ Updated 10:12 PM. Check out the latest RAPT Therapeutics, Inc. and changed its name to RAPT Therapeutics, Inc. RAPT RAPT Therapeutics Stock Price and Discussion Stocktwits. The company was formerly known as FLX Bio, Inc.
, you can buy Rapt Therapeutics Inc stock in any dollar amount, or any other fund or stock you know on Stash.
RAPT THERAPEUTICS STOCK PRICE FULL
It is also pursuing a range of targets, including general control nonderepressible 2 and hematopoietic progenitor kinase 1 that are in the discovery stage of development. Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share. The company's lead inflammation drug candidate is RPT193 to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
RAPT THERAPEUTICS STOCK PRICE TRIAL
Its lead oncology drug candidate is FLX475, an oral small molecule C-C motif chemokine receptor 4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases.